Dechra Pharmaceuticals plc with EPIC/TICKER (LON:DPH) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘OVERWEIGHT’ this morning by analysts at JP Morgan Cazenove. Dechra Pharmaceuticals plc are listed in the Health Care sector within UK Main Market. JP Morgan Cazenove have set their target price at 3500 GBX on its stock. This now indicates the analyst believes there is a possible upside of 18.2% from today’s opening price of 2962 GBX. Over the last 30 and 90 trading days the company share price has increased 164 points and increased 230 points respectively. The 52 week high share price is 3080 GBX while the 52 week low is 1992 GBX.
Dechra Pharmaceuticals plc has a 50 day moving average of 2,917.80 GBX and a 200 day moving average of 2,616.88. There are currently 102,651,602 shares in issue with the average daily volume traded being 190,572. Market capitalisation for LON:DPH is £3,015,904,066 GBP.
